04/15/2019 | Ramona Howard
Could OCT-A be used as a diagnostic tool for Alzheimer's disease?
04/03/2019 | Sponsored by Alimera
Addressing the challenge of diabetic macular edema with ILUVIEN®: views from the Expert User Group Meeting in Rome, November 17, 2018
04/02/2019 | Phoebe Harkin
Could nitisinone increase melanin production in patients with albinism?
04/02/2019 | Aleksandra Jones
The image shows en face OCT visualization of macular photoreceptor loss in choroideremia
03/12/2019
Sitting Down With… Paulo Stanga, Consultant Ophthalmologist and Vitreoretinal Surgeon, Manchester Royal Eye Hospital
03/08/2019 | Robert MacLaren
Gene therapies are no longer just hype – they provide tangible benefits to real patients, today
03/07/2019 | James Bainbridge
Tomorrow’s cures for retinopathies will likely include advanced gene and cell therapies delivered by precision surgery
03/05/2019 | Aleksandra Jones
Our newfound ability to harness the power of gene therapy is facing an age-old challenge: financial constraints
03/05/2019 | Michel Michaelides
Reflecting on the past – and future – of gene therapy
03/05/2019 | Mariya Moosajee
Plasmid vectors are gaining traction as a viable alternative in gene therapy delivery
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: